RU Okay? Understanding the Regulatory Landscape for Diagnostic Tests in the US, UK and EU - McDermott Will & Emery

RU Okay? Understanding the Regulatory Landscape for Diagnostic Tests in the US, UK and EU

Overview


Join us for an informative discussion on the evolving landscape of In Vitro Diagnostics (IVD) and Lab Developed Tests (LDTs). Our panel of industry leaders will delve into the latest developments from across the US, UK and Europe.

REGISTER

3:00 – 4:00 pm (GMT)
4:00 – 5:00 pm (CET)
10:00 – 11:00 am (EST)

Complimentary Webinar

Agenda


  • The FDA’s proposed rule on LDTs issued in September 2023 – what will this mean for test providers and manufacturers?
  • The landscape for Research Use Only and LDTs in the US, UK and Europe – what are the current exemptions?
  • EU IVDR timelines and extensions – the current transition and understanding when a change is significant
  • Compliance with the new standards – what do you need to know about clinical evidence and timelines to certification?
  • The UK IVD current landscape and the timelines for proposed new regulations – what flexibility is there?

SPEAKERS


Alex Laan, Head of the IVD Notified Body, BSI

Stephen Lee, Director, Diagnostics Regulation, ABHI

 

Dig Deeper

London, United Kingdom / McDermott Event / September 19, 2024

HPE Europe 2024

New York, NY / McDermott Event / June 4, 2024

InsurTech Summit 2024

Chicago, IL / Speaking Engagements / May 14, 2024

Modern Healthcare Digital Health Summit: Patients and Trust

Nashville, TN / McDermott Event / May 17, 2024

Value-Based Care Symposium 2024

Nashville, TN / McDermott Event / May 15-16, 2024

Physician Practice Management and ASC Symposium 2024

Boston, MA / Speaking Engagements / May 8-9, 2024

LSPN North America – Spring 2024